Alle News zum Sektor Gesundheit

 

Teva Pharmaceuticals CEO Richard Francis talks about innovation and sales growth at the company with Bloomberg's Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.  (Source: Bloomberg)...

AstraZeneca CFO Aradhana Sarin discusses the company's M&A strategy and weight-loss portfolio with Katie Greifeld at the JPMorgan Health-Care Conference in San Francisco. (Source: Bloomberg)...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Friday,......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Benco Dental will offer Dentsply Sirona's full portfolio of dental technology solutions, in addition to the consumables portfolio. Expanding the decades-long relationship reflects a shared vision to advance connected dentistry by facilitating access to an integrated ecosystem that connects devices, software, and people—from scanning to designing and manufacturing—for greater efficiency and better patient outcomes....

Preliminary total global full year 2025 revenue of approximately $616 million...

SANTA CLARA, Kalifornien (IT-Times) - Nvidia und Eli Lilly haben eine weitreichende strategische Zusammenarbeit angekündigt, um die Medikamentenforschung zu revolutionieren. Die Nvidia Corp. (Nasda......

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.  (Source: Bloomberg)...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Bristol Myers Squibb Co. said about 5% of Opdivo patients are taking a new, easier-to-use version of the blockbuster cancer drug and said it's on course to meet the company's goal of adoption by at least 30% of patients in two years....

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced it awarded an inducement grant on January 10, 2026 under BBOT's 2025 Inducement Plan as a material inducement to the employment of an individual hired by BBOT in December 2025....

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced its preliminary, unaudited net sales for the fourth quarter and full year ended December 31, 2025, and reaffirmed its full year 2026 revenue guidance. Preliminary and unaudited total net sales for the fourth quarter of 2025 are expected to be approximately $143 million, a reported increase of 36% compared to the same period in 2024, consisting of approximately $86 million in U.S. Glaucoma net sales, including iDose® TR net sales of approximately $45 million, approximately $33 million in International Glaucoma net sales, and approximately $24 million in Corneal Health net sales. Preliminary and unaudited total net sales for the full year of 2025 are expected to be approximately $507 million, a reported increase of 32% compared to the full year of 2024, consisting of appr...

Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States. read more...

BioNTech SE is flexible about its future structure as it prepares to bring a slew of cancer drugs to market, with its chief executive officer saying he would consider a deal with a partner that gets preferred access to some medicines....

Regeneron Chief Scientific Officer George Yancopoulos joins Bloomberg's Katie Greifeld at the annual JP Morgan healthcare conference in San Francisco to talk about the FDA's response to their hearing loss gene therapy as well as their plans to roll out weight loss drugs. (Source: Bloomberg)...

On today's episode of CNBC Crypto World, major cryptocurrencies trade higher after new data showed inflation was lower than expected in December. Plus, the Senate Banking Committee releases the full text of proposed market structure legislation ahead of its markup this week. And, Polygon Labs CEO Marc Boiron discusses the firm's acquisitions of crypto payments company Coinme and digital asset infrastructure provider Sequence in moves geared at expanding Polygon's footing in stablecoin payments....

LOS ANGELES, Jan. 13, 2026 /PRNewswire/ -- St. Cloud Capital is pleased to announce a recent investment in Integrated Diagnostic Services ("IDS" or the "Company") for its acquisition of Core Analytics Lab & Radiology ("Core"), a leading provider of mobile radiology and laboratory services......

Um den gesamten Artikel unter apnews.com zu lesen, klicken Sie bitte auf die Überschrift...